|
29 Oct 2018 |
Social |
European Commission (EC) has approved a label update for Cosentyx (secukinumab), now allowing up to 300 mg dosing and also includes 24-week Xray data with inhibition of progression of joint damage in PsA https://t.co/S6d4XE75Ov |
|
|
26 Oct 2018 |
Social |
RT @rheumatol123: #Methotrexate and #leflunomide survival in #patients with #psoriatic #arthritis
Know more: https://t.co/kGlBeVFDzb https:… |
|
|
26 Oct 2018 |
Social |
RT @drdavidliew: It’s the psoriatic arthritis equivalent of watching Coltrane, Louis Armstrong and Duke Ellington on the same stage #ACR18… |
|
|
25 Oct 2018 |
Social |
RT @PhilipGardiner: Abst 651 Baraliakos MRI reports on SI joints in #AS differ between radiologists and rheumatologist: edema+erosion works… |
|
|
25 Oct 2018 |
ACR Video |
Dr. Cush: Best Thing I Saw Today in PsA |
|
|
25 Oct 2018 |
Social |
RT @synovialjoints: Genetic Risk score prediction in Ankylosing Spondylitis using nearly 4000 SNPs in the European cohort showed performanc… |
|
|
25 Oct 2018 |
Social |
RT @synovialjoints: Interesting study of JAK-1 inhibitor in ankylosing spondylitis #ankylosingspondylitis #rheum #ACR18 https://t.co/c423eX… |
|
|
24 Oct 2018 |
News |
Updates on Psoriatic Arthritis at ACR 2018 |
|
|
24 Oct 2018 |
ACR Video |
Drs. Mease, Cush and Ruderman: Psoriatic Arthritis |
|
|
24 Oct 2018 |
Social |
RT @ArthurRheum: Pooled analysis from 3 PSA+12 PSO trials on ixekizumab RCTs. Reassuring that incidence of IBD relatively low with signific… |
|
|
24 Oct 2018 |
Social |
RT @ArthurRheum: ETN plus MTX combo better for skin PSO outcomes, but not a huge improvement for joints... but remember this study used ETN… |
|
|
24 Oct 2018 |
Social |
RT @Janetbirdope: ACR highlights. Many Scleroderma trials were close to positive. Tocilizumab, Abatacept & Riociguat. In PsA safety and eff… |
|
|
24 Oct 2018 |
Social |
RT @samwhittle: #ACR18 #2925 - Fascinating study by Xenofon Baraliakos: vertebral fatty lesions (defined by MRI) in AS biopsied at spinal s… |
|
|
24 Oct 2018 |
News |
Axial Spondylitis Abstracts Roundup |
|
|
23 Oct 2018 |
Social |
RT @samwhittle: #ACR18 Late Breaking Abstracts
#L17 Bimekizumab (anti-IL17 A & F) in PsA. Superior ACR50 vs PBO at wk 12, increase in respo… |
|
|
23 Oct 2018 |
Social |
RT @ArthurRheum: European cohort study shows RA and SpA patients switched from Enbrel to SB4 had similar DAS28 and BASDAI respectively at 3… |
|
|
23 Oct 2018 |
News |
NK cells and a Potential Role in the Development of PsA vs PsC (Cutaneous Psoriasis) |
|
|
23 Oct 2018 |
News |
What is the Future of MTX for Psoriatic Arthritis? |
|
|
23 Oct 2018 |
News |
ACR 2018 - Day 2 Report |
|
|
23 Oct 2018 |
ACR Video |
Dr. Atul Deodhar: Inflammatory Bowel Disease |
|
